Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:483-488
Published online before print July 26, 2004, doi: 10.1161/01.CIR.0000137117.87589.88
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/5/483    most recent
01.CIR.0000137117.87589.88v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kholová, I.
Right arrow Articles by Kautzner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kholová, I.
Right arrow Articles by Kautzner, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
Related Collections
Right arrow Structure
Right arrow Ablation/ICD/surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2004;110:483-488.)
© 2004 American Heart Association, Inc.


Original Articles

Morphology of Atrial Myocardial Extensions Into Human Caval Veins

A Postmortem Study in Patients With and Without Atrial Fibrillation

Ivana Kholová, MD, PhD; Josef Kautzner, MD, PhD, FESC

From the AI Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland, and Fingerland’s Department of Pathology, Charles University Medical School, Hradec Králové, and the Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague (J.K.), Czech Republic.

Correspondence to Josef Kautzner, MD, PhD, FESC, Department of Cardiology, Institute for Clinical and Experimental Medicine, Videnská 1958/9, 140 21 Prague 4, Czech Republic. E-mail joka{at}medicon.cz

Received September 3, 2003; de novo received January 6, 2004; revision received April 6, 2004; accepted April 8, 2004.

Background— Atrial fibrillation (AF) may be triggered from arrhythmogenic foci originating from atrial muscular sleeves that extend into the caval veins (CVs). The aim of this anatomic study was to evaluate both the extent and arrangement of atrial myocardial fibers in CVs in subjects with and without a history of AF.

Methods and Results— Twenty-five human autopsied hearts (15 men; mean age, 65.5±12 years; range, 39 to 80 years) were studied. Seven subjects had a previous history of AF. The presence and morphology of atrial myocardial extensions were studied microscopically in both CVs. Such extensions were found in 38 of 50 CVs (76%). Their average length in the superior vena cava reached 13.7±13.9 mm (maximum, up to 47 mm) and in the inferior vena cava, 14.6±16.7 mm (maximum, up to 61 mm). The thickness of atrial myocardium extending into the CVs was 1.2±1.0 mm (maximum, 4 mm) for the superior vena cava and 1.2±0.9 mm for the inferior vena cava (maximum, 3 mm). The majority of myocardial extensions revealed discontinuous and circular patterns. Degenerative changes were found in approximately half of the subjects. There was no significant difference between patients with and without a history of AF.

Conclusions— Atrial myocardial extensions into both CVs are present in the majority of human beings, both with and without a history of AF. The extensions are localized on the outer side of venous adventitia. Arrangement, length, and thickness of myocardial sleeves onto the CVs vary individually, and many of them contain degenerative changes.


Key Words: fibrillation • veins • myocardium • catheter ablation




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
C. Zhao, J. Qi, X. Liu, H. Chen, J. Li, Y. Liu, L. Liang, Y. Zhang, J. Xiao, L. Li, et al.
Refractoriness of the Sheep Superior Vena Cava Myocardial Sleeve
Experimental Biology and Medicine, November 1, 2008; 233(11): 1441 - 1447.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
E. Buch and K. Shivkumar
Exploring the potential of pulmonary vein recordings: can they help elucidate mechanisms of paroxysmal atrial fibrillation?
Europace, June 1, 2008; 10(6): 690 - 691.
[Full Text] [PDF]


Home page
EuropaceHome page
X.-H. Wang, X. Liu, Y.-M. Sun, H.-F. Shi, L. Zhou, and J.-N. Gu
Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study
Europace, May 1, 2008; 10(5): 600 - 605.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
F. Saremi and S. Krishnan
Cardiac Conduction System: Anatomic Landmarks Relevant to Interventional Electrophysiologic Techniques Demonstrated with 64-Detector CT
RadioGraphics, November 1, 2007; 27(6): 1539 - 1565.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. S. Thornton, M. Rivero-Ayerza, J. M. Mekel, and L. Jordaens
Bidirectional superior vena cava: right atrial conduction delay during tachycardia
Europace, May 1, 2007; 9(5): 302 - 304.
[Abstract] [Full Text] [PDF]